Improving Representation of Underserved Populations in Cardiovascular Research
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.038020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Irving K Loh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ventura Heart Institute Thousand Oaks CA USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Vulnerable Populations, Patient Selection, Medically Underserved Area. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Within the United States, cardiovascular disease is the leading cause of death. There are well‐established inequities in cardiovascular care; individuals from medically underserved populations—including those with low socioeconomic status, rural populations, a plethora of racial and ethnic groups, women, and those living with disabilities—are often at increased risk of cardiovascular morbidity and mortality. Despite their critically unmet needs, these populations remain underrepresented within cardiovascular clinical trials, therefore deepening inequities in cardiovascular care. The inclusion of representative populations within cardiovascular clinical research ensures that data derived from clinical trials translate into effectiveness for all populations, particularly as cardiovascular therapeutics move toward personalized approaches. In this article, we review the importance of including underserved populations in cardiovascular clinical research and the key barriers to their participation. We explore system‐level strategies that have only recently demonstrated large‐scale feasibility within the cardiovascular research paradigm, such as community‐engaged research and clinical trial decentralization, to increase access and engage underserved communities. Decentralizing clinical trials can overcome many of the barriers associated with performing clinical trials at traditional study sites. Additionally, increasing clinical trial workforce diversity and including community clinicians and stakeholders during study design, recruitment, and administration can improve representation within clinical trials. Finally, we propose a holistic approach to improving the diversity of cardiovascular clinical trial participants through the application of the hub‐and‐spoke organizational model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ventura Heart Institute Thousand Oaks CA USA.
- Massachusetts General Hospital Harvard Medical School Boston MA USA.
- Heart and Vascular Center Brigham and Women's Hospital, Harvard Medical School Cambridge MA USA.
- Your Total Health Clinic and Day Spa Houston TX USA.
ORCID-Profile: Irving K Loh, Tyler E Miller, Rahul Aggarwal
Zitieren
APA
Loh, I. K., Miller, T. E., Aggarwal, R., & Richmond, T. M. (2025). Improving Representation of Underserved Populations in Cardiovascular Research. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038020
Vancouver
Loh IK, Miller TE, Aggarwal R, Richmond TM. Improving Representation of Underserved Populations in Cardiovascular Research. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038020
BibTeX
@article{Loh2025,
author = {Loh, Irving K and Miller, Tyler E and Aggarwal, Rahul and Richmond, Teriya M},
title = {Improving Representation of Underserved Populations in Cardiovascular Research},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.038020}
}
EUVIMED